Report on Ramdev's Patanjali Accusing a "Mafia" Following the Alleged Prohibition of 5 Medicinal Products in Uttarakhand

In a recent turn of events, the Uttarakhand government has taken action against Patanjali Ayurved, one of India's leading Ayurvedic companies. Reports suggest that the Ayurveda and Unani Licensing Authority in Dehradun has ordered Patanjali's pharmaceutical arm, Divya Pharmacy, to halt the production of five of its medicines: Madhugrit, Eyegrit, Thyrogrit, BPgrit, and Lipidom.

The action was initiated in response to a complaint filed by Kerala-based eye doctor KV Babu in July. The complaint did not specify the exact nature of the deceptive promotions, but the order accuses Patanjali of such practices. The company, however, denies receiving a copy of the order and claims it has not been provided with the details of the allegations.

The five products in question are advertised as treatments for high blood pressure, diabetes, goitre, glaucoma, and high cholesterol. Patanjali Ayurved products are made following suggested criteria, meeting all legal procedures and global standards. The company employs over 500 scientists to ensure high research and quality in Ayurveda practice.

In a statement, Patanjali Sansthan threatened to take legal action against the individuals involved in the conspiracy, or against the department if they do not remedy their mistake. The company insists that it has not suffered any institutional loss due to the reported ban on five of its products.

This is not the first time Patanjali Ayurved has been embroiled in a controversy. The company has previously faced allegations of false claims in its advertising. The company has, in the past, vehemently denied such accusations.

The order was issued by Dr GCS. Jangpangi, certificate police officer, Uttarakhand Ayurvedic and Unani Providers. The complaint was reported by The Hindu and Hindustan Times. KV Babu sent an additional complaint to the State Licensing Authority on October 11, but the search results do not contain information about the identity of KV Babu, nor about the relevance of his identity to the incident at Patanjali Ayurved. Therefore, based on the provided data, KV Babu's identity and its significance remain unknown.

The Patanjali group's pharmaceutical company, Divya Drug store, has accused an "anti-Ayurveda medication mafia" of a conspiracy. The company maintains that it will continue to uphold the principles of Ayurveda and will fight against any attempts to undermine its practices and products.

As the situation unfolds, Patanjali Ayurved and the Uttarakhand government will likely face further scrutiny and debate. The company has vowed to take legal action against those responsible for the alleged deceptive promotions, while the government stands firm on its decision to uphold the integrity of Ayurvedic practices in the state.

Report on Ramdev's Patanjali Accusing a "Mafia" Following the Alleged Prohibition of 5 Medicinal Products in Uttarakhand